Daniel W Mcdonald Iii, PHD | |
2910 Horizon Park Dr Ste A, Suwanee, GA 30024-7256 | |
(770) 271-8989 | |
(770) 932-8297 |
Full Name | Daniel W Mcdonald Iii |
---|---|
Gender | Male |
Speciality | Psychologist - Counseling |
Location | 2910 Horizon Park Dr Ste A, Suwanee, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750320438 | NPI | - | NPPES |
0515016 | Medicaid | AL | |
051501699 | Other | AL | BC BS OF AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC1900X | Psychologist - Counseling | PSY003464 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Daniel W Mcdonald Iii, PHD 2910 Horizon Park Dr Ste A, Suwanee, GA 30024-7256 Ph: (770) 271-8989 | Daniel W Mcdonald Iii, PHD 2910 Horizon Park Dr Ste A, Suwanee, GA 30024-7256 Ph: (770) 271-8989 |
News Archive
Most of our cells possess an internal clock, a group of genes displaying a cyclic expression pattern that reaches a peak once a day. A large number of circadian genes are expressed by organs such as the liver, whose activity needs to be precisely regulated over the course of the day.
A.P. Pharma, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company's resubmission of its New Drug Application (NDA) for APF530.
Teens are not consuming enough whole grain foods, according to a recent study from the University of Minnesota at St. Paul and featured in the January issue of Food Nutrition & Science.
An internationally recognized melanoma researcher at Moffitt Cancer Center and colleagues at the University of Kiel in Germany, including Axel Hauschild, M.D. and Katharina C. K-hler, M.D., have published an article in the current issue of The Journal of Clinical Oncology that describes immune-related adverse events for patients receiving either tremelimumab or ipilimumab, the latter a drug approved last year by the U.S. Food and Drug Administration for treating metastatic melanoma and other cancers.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.
› Verified 9 days ago
Dr. Sarah Leon, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 2910 Horizon Park Dr, Suite A, Suwanee, GA 30024 Phone: 770-271-8989 Fax: 770-932-8297 | |
Dr. Jeff Weber, ED.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4411 Suwanee Dam Road, Ste. 920, Suwanee, GA 30024 Phone: 678-714-9590 Fax: 678-714-4953 | |
Liza Amanda Weber, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5050 Research Ct Ste 800, Suwanee, GA 30024 Phone: 678-749-7600 | |
Dr. Norris Elliot Currence Jr., PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 945 Pebble Creek Trl, Suwanee, GA 30024 Phone: 954-609-1351 | |
Dr. Barry Leonard Klein, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3325 Paddocks Pkwy Ste 415, Suwanee, GA 30024 Phone: 404-216-0336 Fax: 678-513-1188 | |
Dr. Anja Schoeke, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5050 Research Ct Ste 800, Suwanee, GA 30024 Phone: 787-497-6006 | |
Dr. Scott Alan Duncan, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 2910 Horizon Park Dr Ste A, Suwanee, GA 30024 Phone: 770-271-8989 |